首页 > 最新文献

Neurosurgical Review最新文献

英文 中文
Comment on - Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis. 评论 - 对于新诊断的胶质母细胞瘤,在替莫唑胺和放疗的基础上加用贝伐单抗是否与临床效用相关?系统回顾和荟萃分析。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02934-8
Hethesh Chellapandian, Sivakamavalli Jeyachandran
{"title":"Comment on - Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis.","authors":"Hethesh Chellapandian, Sivakamavalli Jeyachandran","doi":"10.1007/s10143-024-02934-8","DOIUrl":"https://doi.org/10.1007/s10143-024-02934-8","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Treatment factors to suppress delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage based on VASOGRADE: multicenter cohort study". 就 "基于 VASOGRADE 的动脉瘤性蛛网膜下腔出血后抑制延迟性脑缺血的治疗因素:多中心队列研究 "发表评论。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02973-1
Karthikeyan Kandaswamy, Ajay Guru
{"title":"Comment on \"Treatment factors to suppress delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage based on VASOGRADE: multicenter cohort study\".","authors":"Karthikeyan Kandaswamy, Ajay Guru","doi":"10.1007/s10143-024-02973-1","DOIUrl":"https://doi.org/10.1007/s10143-024-02973-1","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Comparison of LVIS and enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study". 关于 "LVIS 和企业支架辅助卷曲栓塞治疗颅内动脉瘤破裂的比较:倾向得分匹配队列研究 "的评论。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02972-2
Vanitha Marunganathan, Ajay Guru
{"title":"Comment on \"Comparison of LVIS and enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study\".","authors":"Vanitha Marunganathan, Ajay Guru","doi":"10.1007/s10143-024-02972-2","DOIUrl":"https://doi.org/10.1007/s10143-024-02972-2","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric skull fractures: neurosurgical approaches and long-term outcomes. 小儿颅骨骨折:神经外科手术方法和长期疗效。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02966-0
Mayur Wanjari, Roshan Prasad
{"title":"Pediatric skull fractures: neurosurgical approaches and long-term outcomes.","authors":"Mayur Wanjari, Roshan Prasad","doi":"10.1007/s10143-024-02966-0","DOIUrl":"https://doi.org/10.1007/s10143-024-02966-0","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zygomatic Anterolateral Temporal Approach for P1/P2 segment complex posterior cerebral aneurysm: a single-center retrospective study. 颧骨颞前外侧入路治疗 P1/P2 段复杂后脑动脉瘤:一项单中心回顾性研究。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02875-2
Maohua Ding, Zhenhua Huang, Xiaoguang Tong

Treating complex posterior cerebral artery (PCA) aneurysms, such as fusiform, giant, and dissecting aneurysms, poses significant challenges. Parent artery occlusion carries a risk of ischemic stroke and fails to alleviate mass effects. This study aims to analyze the technical nuances and patient outcomes of treating complex PCA aneurysms, ranging from the P1 to P2P segments, using a Zygomatic Anterolateral Temporal Approach(ZATA) combined with flow reconstruction. This study was a retrospective study. Surgical treatment was performed on twelve patients with complex PCA aneurysms located in the P1 to P2P segments. Ten patients underwent flow reconstruction including Superficial Temporal Artery(STA)-Middle Cerebral Artery(MCA),Internal Maxillary Artery(IMA)-Radial Artery(RA)-MCA,STA-PCA(P2), and IMA-RA-PCA(P2). The aneurysm occlusion rate, surgical complications, and patient prognosis, including stroke occurrence/ modified Rankin Scale(mRS), were recorded and analyzed. Using the ZATA, all twelve complex PCA aneurysms were successfully clipped/resected/trapped. This included two high-position aneurysms (> 3 mm above the posterior clinoid process) at the P1/P2 junction and three P2P aneurysms. The mass effects of six large or giant aneurysms were resolved or alleviated. Postoperative and follow-up CTA/DSA confirmed the patency of the bypass vessels. Four patients experienced strokes in the perioperative period, with three ischemic and one hemorrhagic. The median follow-up period was 28.5 months. At the last follow-up, the good prognosis rate (mRS ≤ 2) was 83.3%, and one patient had died. Clipping/resection/trapping of aneurysms via the ZATA, combined with flow reconstruction, is a feasible option for treating complex PCA aneurysms from the P1 to P2P segments. This approach helps maintain or improve cerebral perfusion in the affected vascular territory.

治疗复杂的大脑后动脉(PCA)动脉瘤(如纺锤形动脉瘤、巨大动脉瘤和剥脱性动脉瘤)是一项重大挑战。母动脉闭塞有缺血性中风的风险,而且无法减轻肿块效应。本研究旨在分析使用颧骨颞前外侧入路(ZATA)结合血流重建治疗从P1到P2P段的复杂PCA动脉瘤的技术细节和患者预后。本研究是一项回顾性研究。12名患有复杂PCA动脉瘤的患者接受了手术治疗,动脉瘤位于P1至P2P段。十名患者接受了血流重建,包括颞浅动脉(STA)-大脑中动脉(MCA)、颌内动脉(IMA)-桡动脉(RA)-MCA、STA-PCA(P2)和 IMA-RA-PCA(P2)。记录并分析了动脉瘤闭塞率、手术并发症和患者预后,包括卒中发生率/改良Rankin量表(mRS)。使用ZATA,所有12个复杂的PCA动脉瘤都被成功剪切/切除/夹闭。其中包括两个位于P1/P2交界处的高位动脉瘤(高于后clinoid突3毫米)和三个P2P动脉瘤。六个大的或巨大的动脉瘤的肿块效应已经消除或减轻。术后和随访的 CTA/DSA 证实了旁路血管的通畅。四名患者在围手术期发生了中风,其中三名为缺血性,一名为出血性。中位随访时间为 28.5 个月。最后一次随访时,预后良好率(mRS ≤ 2)为 83.3%,一名患者死亡。通过 ZATA 对动脉瘤进行剪切/切除/夹闭,并结合血流重建,是治疗 P1 至 P2P 段复杂 PCA 动脉瘤的可行方案。这种方法有助于维持或改善受影响血管区域的脑灌注。
{"title":"Zygomatic Anterolateral Temporal Approach for P1/P2 segment complex posterior cerebral aneurysm: a single-center retrospective study.","authors":"Maohua Ding, Zhenhua Huang, Xiaoguang Tong","doi":"10.1007/s10143-024-02875-2","DOIUrl":"https://doi.org/10.1007/s10143-024-02875-2","url":null,"abstract":"<p><p>Treating complex posterior cerebral artery (PCA) aneurysms, such as fusiform, giant, and dissecting aneurysms, poses significant challenges. Parent artery occlusion carries a risk of ischemic stroke and fails to alleviate mass effects. This study aims to analyze the technical nuances and patient outcomes of treating complex PCA aneurysms, ranging from the P1 to P2P segments, using a Zygomatic Anterolateral Temporal Approach(ZATA) combined with flow reconstruction. This study was a retrospective study. Surgical treatment was performed on twelve patients with complex PCA aneurysms located in the P1 to P2P segments. Ten patients underwent flow reconstruction including Superficial Temporal Artery(STA)-Middle Cerebral Artery(MCA),Internal Maxillary Artery(IMA)-Radial Artery(RA)-MCA,STA-PCA(P2), and IMA-RA-PCA(P2). The aneurysm occlusion rate, surgical complications, and patient prognosis, including stroke occurrence/ modified Rankin Scale(mRS), were recorded and analyzed. Using the ZATA, all twelve complex PCA aneurysms were successfully clipped/resected/trapped. This included two high-position aneurysms (> 3 mm above the posterior clinoid process) at the P1/P2 junction and three P2P aneurysms. The mass effects of six large or giant aneurysms were resolved or alleviated. Postoperative and follow-up CTA/DSA confirmed the patency of the bypass vessels. Four patients experienced strokes in the perioperative period, with three ischemic and one hemorrhagic. The median follow-up period was 28.5 months. At the last follow-up, the good prognosis rate (mRS ≤ 2) was 83.3%, and one patient had died. Clipping/resection/trapping of aneurysms via the ZATA, combined with flow reconstruction, is a feasible option for treating complex PCA aneurysms from the P1 to P2P segments. This approach helps maintain or improve cerebral perfusion in the affected vascular territory.</p>","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "A randomized controlled trial of social media promotion in neurosurgical publishing". 就 "神经外科出版中社交媒体推广的随机对照试验 "发表评论。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02942-8
Karthikeyan Kandaswamy, Ajay Guru
{"title":"Comment on \"A randomized controlled trial of social media promotion in neurosurgical publishing\".","authors":"Karthikeyan Kandaswamy, Ajay Guru","doi":"10.1007/s10143-024-02942-8","DOIUrl":"https://doi.org/10.1007/s10143-024-02942-8","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advantage and challenges in the use of 5-Aminolevulinic acid (5-ALA) in neurosurgery. 在神经外科中使用 5-Aminolevulinic acid (5-ALA) 的优势和挑战。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02974-0
Magdalena Rybaczek, Bipin Chaurasia
{"title":"Advantage and challenges in the use of 5-Aminolevulinic acid (5-ALA) in neurosurgery.","authors":"Magdalena Rybaczek, Bipin Chaurasia","doi":"10.1007/s10143-024-02974-0","DOIUrl":"https://doi.org/10.1007/s10143-024-02974-0","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of pediatric epidural hematoma: a neurosurgical perspective. 小儿硬膜外血肿的处理:神经外科的视角。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s10143-024-02961-5
Mayur Wanjari, Roshan Prasad
{"title":"Management of pediatric epidural hematoma: a neurosurgical perspective.","authors":"Mayur Wanjari, Roshan Prasad","doi":"10.1007/s10143-024-02961-5","DOIUrl":"https://doi.org/10.1007/s10143-024-02961-5","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on - Improving surgical outcomes of chronic subdural hematoma surgery: an umbrella review and meta-analyses guidance for neurosurgeons. 评论 - 改善慢性硬膜下血肿手术疗效:神经外科医生的总体回顾和荟萃分析指南。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-30 DOI: 10.1007/s10143-024-02935-7
Hethesh Chellapandian, Sivakamavalli Jeyachandran
{"title":"Comment on - Improving surgical outcomes of chronic subdural hematoma surgery: an umbrella review and meta-analyses guidance for neurosurgeons.","authors":"Hethesh Chellapandian, Sivakamavalli Jeyachandran","doi":"10.1007/s10143-024-02935-7","DOIUrl":"https://doi.org/10.1007/s10143-024-02935-7","url":null,"abstract":"","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic transorbital approach for recurrent spheno-orbital meningiomas: single center case series. 经眶内镜方法治疗复发性眶隔脑膜瘤:单中心病例系列。
IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-30 DOI: 10.1007/s10143-024-02905-z
V Ricciuti, E Peppucci, A Montalbetti, G Piras, G Spena, C G Giussani, C Zoia

Endoscopic transorbital approaches (ETOAs) are finding wide application for skull base lesions, particularly for spheno-orbital meningiomas (SOMs). These tumors have high recurrence rates, and second surgery can often represent a challenge. In this study we analyze our experience of management of recurrent SOMs through a slightly modified eyelid crease approach. Between May 2016 and September 2023, in the Department of Neurosurgery of Fondazione IRCCS Policlinico San Matteo (Pavia, Italy), five consecutive recurrent SOMs have been treated using an endoscopic transorbital approach. Demographic data, preoperatory deficits, lesions characteristics, histology, grade of resection, eventual adjuvant treatments, complications, outcome in terms of symptoms improvement and cosmesis, and hospitalization are described. One patient maintained a right lateral rectus muscle palsy that was already present in the preoperatory, no cerebrospinal fluid (CSF) leaks were reported. All patients had postoperative periorbital edema, but no other systemic complication was found. All patients had proptosis improvement, two had visual acuity improvement, and best cosmetic outcome was obtained in all cases. Hospitalization varied between 4 and 6 days. ETOAs in the management of recurrent SOMs are safe and have good outcome. Right selection of patients is mandatory, but when feasible, endoscopic surgery can allow a virgin route to a previously operated tumor, guaranteeing a good strategic option.

内窥镜经眶入路(ETOA)正被广泛应用于颅底病变,尤其是眶隔脑膜瘤(SOMs)。这些肿瘤的复发率很高,二次手术往往是一个挑战。在本研究中,我们分析了通过略微改良的眼睑皱襞方法治疗复发性SOM的经验。2016年5月至2023年9月期间,意大利帕维亚IRCCS Policlinico San Matteo基金会神经外科连续采用经眶内镜方法治疗了5例复发性SOM。本文介绍了患者的人口统计学数据、术前缺陷、病变特征、组织学、切除等级、最终辅助治疗、并发症、症状改善和外观效果以及住院情况。其中一名患者术前已出现右侧直肌麻痹,但未报告有脑脊液(CSF)漏。所有患者术后均出现眶周水肿,但未发现其他全身并发症。所有患者的眼球突出都得到了改善,两名患者的视力得到了改善,所有病例都获得了最佳美容效果。住院时间从 4 天到 6 天不等。ETOA治疗复发性SOMs安全、疗效好。正确选择患者是必要的,但在可行的情况下,内窥镜手术可以为之前做过手术的肿瘤提供一条处女通道,从而保证了良好的战略选择。
{"title":"Endoscopic transorbital approach for recurrent spheno-orbital meningiomas: single center case series.","authors":"V Ricciuti, E Peppucci, A Montalbetti, G Piras, G Spena, C G Giussani, C Zoia","doi":"10.1007/s10143-024-02905-z","DOIUrl":"https://doi.org/10.1007/s10143-024-02905-z","url":null,"abstract":"<p><p>Endoscopic transorbital approaches (ETOAs) are finding wide application for skull base lesions, particularly for spheno-orbital meningiomas (SOMs). These tumors have high recurrence rates, and second surgery can often represent a challenge. In this study we analyze our experience of management of recurrent SOMs through a slightly modified eyelid crease approach. Between May 2016 and September 2023, in the Department of Neurosurgery of Fondazione IRCCS Policlinico San Matteo (Pavia, Italy), five consecutive recurrent SOMs have been treated using an endoscopic transorbital approach. Demographic data, preoperatory deficits, lesions characteristics, histology, grade of resection, eventual adjuvant treatments, complications, outcome in terms of symptoms improvement and cosmesis, and hospitalization are described. One patient maintained a right lateral rectus muscle palsy that was already present in the preoperatory, no cerebrospinal fluid (CSF) leaks were reported. All patients had postoperative periorbital edema, but no other systemic complication was found. All patients had proptosis improvement, two had visual acuity improvement, and best cosmetic outcome was obtained in all cases. Hospitalization varied between 4 and 6 days. ETOAs in the management of recurrent SOMs are safe and have good outcome. Right selection of patients is mandatory, but when feasible, endoscopic surgery can allow a virgin route to a previously operated tumor, guaranteeing a good strategic option.</p>","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurosurgical Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1